Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Other Noncash Income (Expense)

3.0 / 5 stars · 61/101 Roast Me

BIOMARIN PHARMACEUTICAL INC Other Noncash Income (Expense)

BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Noncash Income (Expense) of $5.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06

  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for the quarter ending 2026-06-30 was $160.00K, a 95.25% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for the quarter ending 2026-03-31 was $5.37M, a 324.15% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for the quarter ending 2025-12-31 was $2.71M.
  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for the quarter ending 2025-09-30 was -$2.93M, a 839.65% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for fiscal 2025 was $4.41M.
  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for fiscal 2024 was -$20.14M, a 5616.44% decline from fiscal 2023.
  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for fiscal 2023 was $365.00K, a 82.13% decline from fiscal 2022.
  • BIOMARIN PHARMACEUTICAL INC other noncash income (expense) for fiscal 2022 was $2.04M, a 22.29% decline from fiscal 2021.
Period endOther Noncash Income (Expense) 3 monthOther Noncash Income (Expense) 6 monthOther Noncash Income (Expense) 6 month as first filedOther Noncash Income (Expense) 9 monthOther Noncash Income (Expense) 12 monthOther Noncash Income (Expense) 12 month as first filed
2026-06-30$160.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$5.53M
10-Q · filed 2026-08-06
$8.24M
derived: sum of 3 quarters · filed 2026-08-06
$5.32M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$5.37M
10-Q · filed 2026-05-05
$8.08M
derived: sum of 2 quarters · filed 2026-05-05
$5.16M
derived: sum of 3 quarters · filed 2026-05-05
$8.52M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$2.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$219.00K
derived: sum of 2 quarters · filed 2026-02-26
$3.15M
derived: sum of 3 quarters · filed 2026-08-06
$4.41M
10-K · filed 2026-02-26
2025-09-30-$2.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$437.00K
derived: sum of 2 quarters · filed 2026-08-06
$1.70M
10-Q · filed 2025-10-28
-$19.68M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$3.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$4.63M
10-Q · filed 2026-08-06
$1.92M
10-Q · filed 2025-08-05
-$16.76M
derived: sum of 3 quarters · filed 2026-08-06
-$16.36M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.27M
10-Q · filed 2026-05-05
-$20.12M
derived: sum of 2 quarters · filed 2026-05-05
-$19.73M
derived: sum of 3 quarters · filed 2026-05-05
-$18.74M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$21.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$20.99M
derived: sum of 2 quarters · filed 2026-02-26
-$20.01M
derived: sum of 3 quarters · filed 2026-02-26
-$20.14M
10-K · filed 2026-02-26
2024-09-30$396.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$1.38M
derived: sum of 2 quarters · filed 2025-10-28
$1.25M
10-Q · filed 2025-10-28
$1.40M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$985.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$858.00K
10-Q · filed 2025-08-05
$999.00K
derived: sum of 3 quarters · filed 2026-02-26
$1.58M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$127.00K
10-Q · filed 2025-05-02
$14.00K
derived: sum of 2 quarters · filed 2026-02-26
$599.00K
derived: sum of 3 quarters · filed 2026-02-26
$16.00K
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$141.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$726.00K
derived: sum of 2 quarters · filed 2026-02-26
$143.00K
derived: sum of 3 quarters · filed 2026-02-26
$365.00K
10-K · filed 2026-02-26
2023-09-30$585.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$2.00K
derived: sum of 2 quarters · filed 2024-10-31
$224.00K
10-Q · filed 2024-10-31
$1.57M
derived: sum of 4 quarters · filed 2025-02-24
2023-06-30-$583.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
-$361.00K
10-Q · filed 2024-08-05
$982.00K
derived: sum of 3 quarters · filed 2025-02-24
$1.66M
derived: sum of 4 quarters · filed 2025-02-24
2023-03-31$222.00K
10-Q · filed 2024-04-26
$1.56M
derived: sum of 2 quarters · filed 2025-02-24
$2.25M
derived: sum of 3 quarters · filed 2025-02-24
$2.96M
derived: sum of 4 quarters · filed 2025-02-24
2022-12-31$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24
$2.02M
derived: sum of 2 quarters · filed 2025-02-24
$2.74M
derived: sum of 3 quarters · filed 2025-02-24
$2.04M
10-K · filed 2025-02-24
2022-09-30$682.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$1.40M
derived: sum of 2 quarters · filed 2023-11-02
$700.00K
10-Q · filed 2023-11-02
$2.01M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30$718.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$18.00K
10-Q · filed 2023-08-02
$1.33M
derived: sum of 3 quarters · filed 2024-02-26
$2.27M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31-$700.00K
10-Q · filed 2023-04-28
$612.00K
derived: sum of 2 quarters · filed 2024-02-26
$1.55M
derived: sum of 3 quarters · filed 2024-02-26
$1.06M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$2.25M
derived: sum of 2 quarters · filed 2024-02-26
$1.76M
derived: sum of 3 quarters · filed 2024-02-26
$2.63M
10-K · filed 2024-02-26
2021-09-30$941.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
$446.00K
derived: sum of 2 quarters · filed 2022-10-28
$1.32M
10-Q · filed 2022-10-28
$2.70M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30-$495.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$376.00K
10-Q · filed 2022-08-04
$1.76M
derived: sum of 3 quarters · filed 2023-02-27
$723.00K
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$871.00K
10-Q · filed 2022-04-29
$2.26M
derived: sum of 2 quarters · filed 2023-02-27
$1.22M
derived: sum of 3 quarters · filed 2023-02-27
$1.49M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$1.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$347.00K
derived: sum of 2 quarters · filed 2023-02-27
$614.00K
derived: sum of 3 quarters · filed 2023-02-27
$997.00K
10-K · filed 2023-02-27
2020-09-30-$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
-$771.00K
derived: sum of 2 quarters · filed 2021-10-29
-$388.00K
10-Q · filed 2021-10-29
$1.99M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$267.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$650.00K
10-Q · filed 2021-07-30
$3.02M
derived: sum of 3 quarters · filed 2022-02-25
-$560.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$383.00K
10-Q · filed 2021-04-30
$2.76M
derived: sum of 2 quarters · filed 2022-02-25
-$827.00K
derived: sum of 3 quarters · filed 2022-02-25
$2.76M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$2.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$1.21M
derived: sum of 2 quarters · filed 2022-02-25
$2.37M
derived: sum of 3 quarters · filed 2022-02-25
$2.39M
10-K · filed 2022-02-25
$1.68M
10-K · filed 2020-02-27
2019-09-30-$3.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$1.00K
derived: sum of 2 quarters · filed 2020-11-06
$18.00K
10-Q · filed 2020-11-06
$1.91M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$3.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$3.60M
10-Q · filed 2020-08-05
$5.49M
derived: sum of 3 quarters · filed 2021-02-26
$7.72M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$19.00K
10-Q · filed 2020-05-01
$1.91M
derived: sum of 2 quarters · filed 2021-02-26
$4.14M
derived: sum of 3 quarters · filed 2021-02-26
$3.03M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$1.89M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26
$4.12M
derived: sum of 2 quarters · filed 2021-02-26
$3.01M
derived: sum of 3 quarters · filed 2021-02-26
$2.35M
10-K · filed 2021-02-26
2018-09-30$2.23M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04
$1.12M
derived: sum of 2 quarters · filed 2019-11-04
$459.00K
10-Q/A · filed 2019-11-04
-$819.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
-$1.77M
10-Q · filed 2019-08-02
-$3.05M
derived: sum of 3 quarters · filed 2020-02-27
-$3.90M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$662.00K
10-Q · filed 2019-04-29
-$1.94M
derived: sum of 2 quarters · filed 2020-02-27
-$2.79M
derived: sum of 3 quarters · filed 2020-02-27
-$5.63M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$2.13M
derived: sum of 2 quarters · filed 2020-02-27
-$4.97M
derived: sum of 3 quarters · filed 2020-02-27
-$5.93M
10-K · filed 2020-02-27
2017-09-30-$851.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
-$3.69M
derived: sum of 2 quarters · filed 2018-10-26
-$4.66M
10-Q · filed 2018-10-26
-$3.95M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$2.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
-$3.81M
10-Q · filed 2018-08-03
-$3.10M
derived: sum of 3 quarters · filed 2019-02-28
-$3.44M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$969.00K
10-Q · filed 2018-04-27
-$261.00K
derived: sum of 2 quarters · filed 2019-02-28
-$600.00K
derived: sum of 3 quarters · filed 2019-02-28
-$779.00K
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$708.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$369.00K
derived: sum of 2 quarters · filed 2019-02-28
$190.00K
derived: sum of 3 quarters · filed 2019-02-28
-$336.00K
10-K · filed 2019-02-28
2016-09-30-$339.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
-$518.00K
derived: sum of 2 quarters · filed 2017-10-31
-$1.04M
10-Q · filed 2017-10-31
-$2.45M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$179.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$705.00K
10-Q · filed 2017-08-02
-$2.11M
derived: sum of 3 quarters · filed 2018-02-26
-$2.45M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$526.00K
10-Q · filed 2017-05-04
-$1.93M
derived: sum of 2 quarters · filed 2018-02-26
-$2.27M
derived: sum of 3 quarters · filed 2018-02-26
-$3.12M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31-$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$1.74M
derived: sum of 2 quarters · filed 2018-02-26
-$2.59M
derived: sum of 3 quarters · filed 2018-02-26
-$2.46M
10-K · filed 2018-02-26
-$2.30M
10-K · filed 2016-02-29
2015-09-30-$338.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$1.19M
derived: sum of 2 quarters · filed 2016-11-03
-$1.06M
10-Q · filed 2016-11-03
-$4.11M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$851.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
-$721.00K
10-Q · filed 2016-08-08
-$3.77M
derived: sum of 3 quarters · filed 2017-02-27
2015-03-31$130.00K
10-Q · filed 2016-05-02
-$2.92M
derived: sum of 2 quarters · filed 2017-02-27
2014-12-31-$3.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$5.19M
10-K · filed 2017-02-27
-$4.51M
10-K · filed 2016-02-29
2014-09-30-$2.14M
10-Q · filed 2015-11-02
2013-12-31-$1.15M
10-K · filed 2016-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05